We constructed a risk model based on the expression levels of these RBPs and found that ADAT2, C2orf15, SRP72, PAICS, RBMS3, APOBEC3G, NOA1, and ACO1 could be used for risk assessment in terms of breast cancer prognosis (Fig. 4A–C). Here, APOBEC3G is linked to breast carcinoma.